Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Drug-induced lupus erythematosus (DILE) is an autoimmune condition that develops as a reaction to certain prescription medications. Unlike systemic lupus erythematosus (SLE), this condition is directly caused by specific drugs and typically resolves when the triggering medication is discontinued. Blood tests play a crucial role in confirming the diagnosis and distinguishing it from other autoimmune conditions.
This test detects PCNA (Proliferating Cell Nuclear Antigen) antibodies using immunofluorescence assay. Some patients with drug-induced lupus may develop these specific autoantibodies as part of their immune response to certain medications. The presence of PCNA antibodies can help support the diagnosis of drug-induced lupus erythematosus, particularly when symptoms are consistent with a lupus-like syndrome triggered by prescription drugs.
Since drug-induced lupus presents with symptoms similar to systemic lupus erythematosus, specific antibody tests are essential for accurate diagnosis. These tests detect autoantibodies that the immune system produces in response to the triggering medication, helping healthcare providers confirm the diagnosis and rule out other autoimmune conditions.
Drug-induced lupus is typically caused by medications such as hydralazine, procainamide, isoniazid, and certain anti-TNF agents. The condition usually develops months to years after starting the triggering medication and commonly affects the joints, skin, and sometimes internal organs. Unlike SLE, drug-induced lupus rarely affects the kidneys or central nervous system.
The information here is for educational purposes only and is not a substitute for professional medical advice. If you suspect you may have drug-induced lupus, especially if you're taking medications known to trigger this condition, consult with a healthcare provider for proper evaluation and testing.